NCT06758752

A Herbal Compound for Eczema

Evaluation of Therapeutic Effects of ZAX.1400.EC.02 a Herbal Compound on Clinical Signs of Skin in Eczema Patients

• Status: Active Not Recruiting
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 110 (actual)
• Sponsor: Fasa University of Medical Sciences · Academic / Other
• Sex: All
• Age: 18 Years – 60 Years
• Healthy volunteers: Not accepted

Summary

The goal of this interventional clinical trial study is to compare ZAX.1400.EC.02 and placebo in Eczema patients. The main question it aims to answer is: • Can treatment with ZAX.1400.EC.02 for 3 weeks improve clinical signs of skin in Eczema patients? Participants will be divided into two groups. One group will use ZAX.1400.EC.02 topically twice daily for 3 weeks and the other group will use placebo topically twice daily for 3 weeks. Researchers will compare treatment and placebo groups to see if there is any improvement in the clinical signs of skin caused by Eczema after treatment with ZAX.1400.EC.02 for 3 weeks.

Conditions

• Eczema
• Atopic Dermatitis
• Inflammation

Interventions

Type	Name	Description
DIETARY_SUPPLEMENT	ZAX.1400.EC.02	ZAX.1400.EC.02, applied twice daily for 3 weeks after enrolment
DRUG	Placebo	Placebo, applied twice daily for 3 weeks after enrolment

Timeline

• Start date: 2023-10-01
• Primary completion: 2026-12-30
• Completion: 2026-12-30
• First posted: 2025-01-06
• Last updated: 2025-01-06

Locations

1 site across 1 country: Iran